CFO Matt Abernethy projected INGREZZA sales for 2025 to range between $2.5 billion and $2.6 billion, reflecting $250 million growth at the midpoint. He noted increased competitive pressure and payer ...

Source: Press Release IGM Biosciences: Dizzying Number Of Pivots IGM to slash 73% of workforce, halt two drug programs Seeking Alpha’s Quant Rating on IGM Biosciences Historical earnings data ...

BTIG analyst Mark Massaro reiterated a Hold rating on Alpha Teknova (TKNO – Research Report) yesterday. The company’s shares closed yesterday ...

Green Alpha Advisors LLC’s holdings in Pacific Biosciences of California were worth $187,000 as of its most recent SEC filing. Other institutional investors also recently added to or reduced ...